Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 17, 2008. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the Deferred Investment Award Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of a specific share transaction rather than a financial performance report.
Material Changes
The filing details an increase in the shareholding of Mr. E J Gray. The transaction involved the re-investment of a dividend paid to shareholders on April 10, 2008, at a price of GBP 11.05 per share. The resulting interest is recorded as 312.41 shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is strictly limited to the disclosure of the director's transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: April 17, 2008
- Individual Involved: Mr. E J Gray
- Transaction Type: Re-investment of dividend under the Deferred Investment Award Plan
- Share Price: GBP 11.05 per share
- Resulting Interest: 312.41 Ordinary shares